Enjoy complimentary customisation on priority with our Enterprise License!
The human chorionic gonadotropin (hCG) market share is expected to increase to USD 303.49 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.7%.
This human chorionic gonadotropin (hCG) market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers human chorionic gonadotropin (hCG) market segmentation by technology (natural source extraction and recombinant technology) and geography (North America, Europe, Asia, and Rest of World (ROW)). The human chorionic gonadotropin (hCG) market report also offers information on several market vendors, including Biocare Medical LLC, Cigna Corp., Cipla Ltd., Ferring B.V., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kamia Biomedical Company, Lee BioSolutions Inc, Lupin Ltd., Merck and Co. Inc., MyBioSource Inc., Prospec Tany Technogene Ltd., Sanzyme P Ltd., Scripps Laboratories Inc., and Sun Pharmaceutical Industries Ltd. among others.
Download the Free Report Sample to Unlock the Human Chorionic Gonadotropin (hCG) Market Size for the Forecast Period and Other Important Statistics
The increase in the prevalence of infertility is notably driving the human chorionic gonadotropin (hCG) market growth, although factors such as the presence of alternative procedures may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the human chorionic gonadotropin (hCG) industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Human Chorionic Gonadotropin (hCG) Market Driver
Key Human Chorionic Gonadotropin (hCG) Market Trend
Key Human Chorionic Gonadotropin (hCG) Market Challenge
This hCG market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global human chorionic gonadotropin (hCG) market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the HCG market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the hCG market encompasses successful business strategies deployed by the key vendors. The human chorionic gonadotropin (hCG) market is concentrated and the vendors are deploying growth strategies such as quality and price to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The human chorionic gonadotropin (hCG) market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the HCG market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the human chorionic gonadotropin market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The rise in the infertility rate in the US population will facilitate the human chorionic gonadotropin (hCG) market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 had a negative impact on the regional market. However, the situation has improved after the lockdowns were lifted, and mass-scale vaccinations which as reduced the transmission rate, such factors have resumed infertility treatment among men and women, which will lead to an increased demand for hCG from the people in North America during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The human chorionic gonadotropin (hCG) market share growth in the natural source extraction segment will be significant during the forecast period. Human chorionic gonadotropin (hCG) is naturally produced in the human placenta by the syncytiotrophoblast. Like any other gonadotropins, they can be extracted from the urine of pregnant women. Purified human menopausal gonadotropin (HMG) is a natural product extracted from the urine of postmenopausal women that contains pituitary follicle-stimulating hormone (FSH), luteinizing hormone (LH), and a small amount of hCG. These factors will drive the segment growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the human chorionic gonadotropin market size and actionable market insights on post COVID-19 impact on each segment.
Human Chorionic Gonadotropin (hCG) Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.7% |
Market growth 2022-2026 |
$ 303.49 million |
Market structure |
Concentrated |
YoY growth (%) |
5.11 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Biocare Medical LLC, Cigna Corp., Cipla Ltd., Ferring B.V., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kamia Biomedical Company, Lee BioSolutions Inc, Lupin Ltd., Merck and Co. Inc., MyBioSource Inc., Prospec Tany Technogene Ltd., Sanzyme P Ltd., Scripps Laboratories Inc., and Sun Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Technology
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.